Similar Papers

Paper Title
Journal
Date
Author
Etoposide and cisplatin (EP) chemotherapy for good risk germ cell tumors (GCT): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
G V Kondagunta ... G J Bosl
Journal of Clinical Oncology | VOL. 22
G V Kondagunta, et. al.G V Kondagunta ... G J Bosl
15 Jul 2004
Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts).
Samuel Funt ... Sujata Patil
Journal of Clinical Oncology | VOL. 36
Samuel Funt, et. al.Samuel Funt ... Sujata Patil
20 May 2018
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
H Xiao ... M Mazumdar
Journal of Clinical Oncology | VOL. 15
H Xiao, et. al.H Xiao ... M Mazumdar
01 Jul 1997
Treatment outcome and incidence for late relapse of germ cell tumor (GCT) patients (pts): The memorial Sloan-Kettering Cancer Center (MSKCC) experience
E A Ronnen ... R J Motzer
Journal of Clinical Oncology | VOL. 23
E A Ronnen, et. al.E A Ronnen ... R J Motzer
01 Jun 2005
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
Sebastian Stintzing ... Volker Heinemann
Journal of Clinical Oncology | VOL. -
Sebastian Stintzing, et. al.Sebastian Stintzing ... Volker Heinemann
04 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy in patients with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma enrolled in the Republic of Korea: KEYNOTE-859.
Sun Young Rha ... Do-Youn Oh
Journal of Clinical Oncology | VOL. 43
Sun Young Rha, et. al.Sun Young Rha ... Do-Youn Oh
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.